These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 8864593)
1. Clinical use of bisphosphonates. Devogelaer JP Curr Opin Rheumatol; 1996 Jul; 8(4):384-91. PubMed ID: 8864593 [TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates in the treatment of metabolic bone diseases. Rodan GA; Balena R Ann Med; 1993 Aug; 25(4):373-8. PubMed ID: 8217103 [TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease. Fleisch H Drugs; 1991 Dec; 42(6):919-44. PubMed ID: 1724640 [TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates: a new class of drugs in diseases of bone and calcium metabolism. Fleisch H Recent Results Cancer Res; 1989; 116():1-28. PubMed ID: 2669065 [TBL] [Abstract][Full Text] [Related]
5. New bisphosphonates in osteoporosis. Fleisch H Osteoporos Int; 1993; 3 Suppl 2():S15-22. PubMed ID: 8481594 [TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates in the treatment of disorders of mineral metabolism. Singer FR; Minoofar PN Adv Endocrinol Metab; 1995; 6():259-88. PubMed ID: 7671099 [TBL] [Abstract][Full Text] [Related]
7. Treatment of bone diseases with bisphosphonates, excluding osteoporosis. Devogelaer JP Curr Opin Rheumatol; 2000 Jul; 12(4):331-5. PubMed ID: 10910187 [TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates: from the laboratory to the clinic and back again. Russell RG; Rogers MJ Bone; 1999 Jul; 25(1):97-106. PubMed ID: 10423031 [TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates: the first 40 years. Russell RG Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003 [TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates in bone diseases. Sparidans RW; Twiss IM; Talbot S Pharm World Sci; 1998 Oct; 20(5):206-13. PubMed ID: 9820883 [TBL] [Abstract][Full Text] [Related]
11. [Bisphosphonates, their mechanism of action and properties useful in the therapy of metabolic bone diseases]. Fojtík Z; Kandusová M Vnitr Lek; 1997 Apr; 43(4):234-7. PubMed ID: 9601843 [TBL] [Abstract][Full Text] [Related]
12. [Development of bisphosphonates]. Nakatsuka K Nihon Rinsho; 2003 Feb; 61(2):219-25. PubMed ID: 12638211 [TBL] [Abstract][Full Text] [Related]
13. Clinical trials with bisphosphonates. Lombardi A; Santora AC Ann Ital Med Int; 1992; 7(3 Suppl):158S-165S. PubMed ID: 1297394 [TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates and the treatment of bone disease in the elderly. Johansen A; Stone M; Rawlinson F Drugs Aging; 1996 Feb; 8(2):113-26. PubMed ID: 8845585 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of action of the bisphosphonates. Fleisch H Medicina (B Aires); 1997; 57 Suppl 1():65-75. PubMed ID: 9567358 [TBL] [Abstract][Full Text] [Related]
16. [Bisphosphonates: indications in bone diseases other than osteoporosis]. Abdelmoula LC; Ben M'barek R; Ben Hadj Yahia C; Tekaya R; Testouri N; Chaabouni L; Zouari R Tunis Med; 2011 Jun; 89(6):511-6. PubMed ID: 21681711 [TBL] [Abstract][Full Text] [Related]
18. [Perspectives on therapy with diphosphonates in non-malignant diseases]. Willvonseder R; Resch H Z Gerontol; 1990; 23(1):39-42. PubMed ID: 2183510 [TBL] [Abstract][Full Text] [Related]
19. From bathtub ring to osteoporosis: a clinical review of the bisphosphonates. Licata AA Cleve Clin J Med; 1993; 60(4):284-90. PubMed ID: 8339454 [TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates in osteoporosis: an introduction. Fleisch H Osteoporos Int; 1993; 3 Suppl 3():S3-5. PubMed ID: 8298201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]